Literature DB >> 27157623

Suppression of intestinal tumors by targeting the mitotic spindle of intestinal stem cells.

R Yao1, J Oyanagi1, Y Natsume1, D Kusama1, Y Kato1, S Nagayama2, T Noda1,3.   

Abstract

Human colorectal cancer is often initiated by the aberrant activation of Wnt signaling, notably following adenomatous polyposis coli (Apc) inactivation. Recent studies identified adult intestinal stem cells (ISCs) and demonstrated their role as the cells of origin for intestinal tumors. However, the early consequences of aberrant Wnt signaling activation remain to be fully elucidated. Here, using organoid cultures established from conditional knockout mice and in vitro gene ablation, we show that Apc inactivation led to aberrant ISC proliferation and the expansion of the crypt domain. This system was used to evaluate the potential of a cancer-related spindle protein, Tacc3, as a target of cancer therapy, as its disruption led to the suppression of tumor formation in an animal model of intestinal tumors. We found that Tacc3 is required for the proper mitosis of Apc-deficient ISCs, and its disruption significantly attenuated the expansion of the crypt domain. In vivo analysis of corresponding mutant mice demonstrated that Tacc3 disruption led to a significant decrease in tumor number and prolonged survival. These observations demonstrated that Tacc3 is a potential chemotherapeutic target for intestinal tumors by perturbing the aberrant cell proliferation of Apc-deficient ISCs and provides an opportunity for the development of novel cancer prevention and treatment.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27157623     DOI: 10.1038/onc.2016.148

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  46 in total

1.  The Lgr5 intestinal stem cell signature: robust expression of proposed quiescent '+4' cell markers.

Authors:  Javier Muñoz; Daniel E Stange; Arnout G Schepers; Marc van de Wetering; Bon-Kyoung Koo; Shalev Itzkovitz; Richard Volckmann; Kevin S Kung; Jan Koster; Sorina Radulescu; Kevin Myant; Rogier Versteeg; Owen J Sansom; Johan H van Es; Nick Barker; Alexander van Oudenaarden; Shabaz Mohammed; Albert J R Heck; Hans Clevers
Journal:  EMBO J       Date:  2012-06-12       Impact factor: 11.598

2.  Restoration of p53 function leads to tumour regression in vivo.

Authors:  Andrea Ventura; David G Kirsch; Margaret E McLaughlin; David A Tuveson; Jan Grimm; Laura Lintault; Jamie Newman; Elizabeth E Reczek; Ralph Weissleder; Tyler Jacks
Journal:  Nature       Date:  2007-01-24       Impact factor: 49.962

3.  Bmi1 is expressed in vivo in intestinal stem cells.

Authors:  Eugenio Sangiorgi; Mario R Capecchi
Journal:  Nat Genet       Date:  2008-06-08       Impact factor: 38.330

4.  Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles.

Authors:  Aravind Subramanian; Pablo Tamayo; Vamsi K Mootha; Sayan Mukherjee; Benjamin L Ebert; Michael A Gillette; Amanda Paulovich; Scott L Pomeroy; Todd R Golub; Eric S Lander; Jill P Mesirov
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-30       Impact factor: 11.205

5.  TACC3 is required for the proper mitosis of sclerotome mesenchymal cells during formation of the axial skeleton.

Authors:  Ryoji Yao; Yasuko Natsume; Tetsuo Noda
Journal:  Cancer Sci       Date:  2007-03-14       Impact factor: 6.716

Review 6.  Beyond taxanes: a review of novel agents that target mitotic tubulin and microtubules, kinases, and kinesins.

Authors:  Michael R Harrison; Kyle D Holen; Glenn Liu
Journal:  Clin Adv Hematol Oncol       Date:  2009-01

7.  Prominin-1/CD133 marks stem cells and early progenitors in mouse small intestine.

Authors:  Hugo J Snippert; Johan H van Es; Maaike van den Born; Harry Begthel; Daniel E Stange; Nick Barker; Hans Clevers
Journal:  Gastroenterology       Date:  2009-03-24       Impact factor: 22.682

8.  Identification of stem cells in small intestine and colon by marker gene Lgr5.

Authors:  Nick Barker; Johan H van Es; Jeroen Kuipers; Pekka Kujala; Maaike van den Born; Miranda Cozijnsen; Andrea Haegebarth; Jeroen Korving; Harry Begthel; Peter J Peters; Hans Clevers
Journal:  Nature       Date:  2007-10-14       Impact factor: 49.962

9.  Phenotypic characterization of human colorectal cancer stem cells.

Authors:  Piero Dalerba; Scott J Dylla; In-Kyung Park; Rui Liu; Xinhao Wang; Robert W Cho; Timothy Hoey; Austin Gurney; Emina H Huang; Diane M Simeone; Andrew A Shelton; Giorgio Parmiani; Chiara Castelli; Michael F Clarke
Journal:  Proc Natl Acad Sci U S A       Date:  2007-06-04       Impact factor: 11.205

10.  Brg1 loss attenuates aberrant wnt-signalling and prevents wnt-dependent tumourigenesis in the murine small intestine.

Authors:  Aliaksei Z Holik; Madeleine Young; Joanna Krzystyniak; Geraint T Williams; Daniel Metzger; Boris Y Shorning; Alan R Clarke
Journal:  PLoS Genet       Date:  2014-07-10       Impact factor: 5.917

View more
  4 in total

Review 1.  A look into centrosome abnormalities in colon cancer cells, how they arise and how they might be targeted therapeutically.

Authors:  Lauren E Harrison; Marina Bleiler; Charles Giardina
Journal:  Biochem Pharmacol       Date:  2017-11-09       Impact factor: 5.858

2.  IFN/STAT signaling controls tumorigenesis and the drug response in colorectal cancer.

Authors:  Mizuho Sakahara; Takuya Okamoto; Jun Oyanagi; Hiroshi Takano; Yasuko Natsume; Hitomi Yamanaka; Daisuke Kusama; Mishio Fusejima; Norio Tanaka; Seiich Mori; Hiroshi Kawachi; Masashi Ueno; Yoshiharu Sakai; Tetsuo Noda; Satoshi Nagayama; Ryoji Yao
Journal:  Cancer Sci       Date:  2019-03-22       Impact factor: 6.716

Review 3.  Insights Into Mechanisms of Oriented Division From Studies in 3D Cellular Models.

Authors:  Federico Donà; Susanna Eli; Marina Mapelli
Journal:  Front Cell Dev Biol       Date:  2022-03-09

4.  E2F1 promotes cell cycle progression by stabilizing spindle fiber in colorectal cancer cells.

Authors:  Zejun Fang; Min Lin; Shenghui Chen; Hong Liu; Minjing Zhu; Yanyan Hu; Shanshan Han; Yizhang Wang; Long Sun; Fengjiao Zhu; Chengfu Xu; Chaoju Gong
Journal:  Cell Mol Biol Lett       Date:  2022-10-11       Impact factor: 8.702

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.